In a first attempt to address this, we took advantage of now having established autologous CAF cell lines from bona fide primary ER+ breast cancer and used these to establish xenografts by co-implantation with ER+ MCF7 breast cancer cells. This evidence concerns the gene ESR1 and breast carcinoma.